Faecal Myeloperoxidase as a Biomarker of Endoscopic Activity in Ulcerative Colitis | ||||
| The Medical Journal of Cairo University | ||||
| Volume 92, Issue 12, December 2024, Page 1331-1343 PDF (225.66 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/mjcu.2024.411422 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| YASSER A. ABDALRAHEEM, M.D.; MOSTAFA M. SAMY, M.Sc. and MOHAMED A. HEWEDY, M.D. .1; MOHAMED A. AWADEIN, M.D.*; AYA AKIL EZZAT, M.B.B.Ch.*; HESHAM S. ABDEL FATTAH, M.D.*; HANAN G. EL-BAZ, M.D.** and BASMA S. KHEREBA, M.D.***2 | ||||
| 1The Department of Neurosurgery, Faculty of Medicine, Beni-Suef University | ||||
| 2The Department of Internal Medicine, Faculty of Medicine, Misr University for Science & Technology*, Clinical Pathology & Immunology, Theodor Bilharz Institute (TBRI)** and Clinical Pathology & Immunology, MUST University*** | ||||
| Abstract | ||||
| Abstract Background: Inflammatory bowel disease (IBD), including Crohn’s disease (CD) and Ulcerative Colitis (UC), is a chron-ic gastrointestinal condition affecting over 6.8 million people globally. It is linked to relapse and remission, necessitating reg-ular monitoring for disease activity. Aim of Study: To evaluate Faecal Myeloperoxidase (fMPO) as a potential marker of activity in patients confirmed to have UC compared to C-reactive protein (CRP) and faecal Calpro-tectin (fCAL), which are the standard laboratory markers to in-itially diagnose activity in quiescent UC. Patients and Methods: This cross-sectional study was con-ductedon 39 patients, divided into 3 groups with ulcerative co-litis attending The Memorial Souad Kafafi University Hospital, Misr University for Science and Technology. Group 1: Newly diagnosed patients (15 patients). Group 2: Patients on No-bi-ological therapy (11 patients). Group 3: Patients of biological therapy (13 patients). Results: The study demonstrated a significant positive cor-relation between fCAL and Mayo score, but no correlation was found between Mayo score and fMPO. However, a significant positive relation was found between fCAL and disease activity groups, with a difference between mild and moderate disease activity groups. The area under curve for fCAL was excellent in distinguishing between moderate and mild disease groups, with a sensitivity of 85.7% and specificity of 87.5%. Conclusion: The study demonstrated that fMPO is effec-tive in stratifying UC patients’ activity, while fCAL showed the best diagnostic ability. Combining markers could improve diagnostics. | ||||
| Keywords | ||||
| Faecal Myeloperoxidase; MPO; A Biomarker; Endoscopic Activity; Ulcerative Colitis | ||||
|
Statistics Article View: 48 PDF Download: 35 |
||||
